Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||ET6956 / UNK||LA / OT|
Administered by: Other Purchased by: ??
Symptoms: Acute respiratory failure, Chronic obstructive pulmonary disease, Lung cancer metastatic, Disease progression
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: acute respiratory failure; advanced lung cancer with multiple metastases; advanced lung cancer with multiple metastases; COPD; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB, regulatory authority number is HU-OGYI-424021. This serious, spontaneous case was reported by a physician on 01Jun2021, concerning the occurrence of death after the use of Comirnaty concentrate for dispersion for injection (MAH: BioNTech Manufacturing). On 22Apr2021, the 65-year-old female patient received 0.3 ml Comirnaty concentrate for dispersion for injection (tozinameran; Lot number: ET6956, expiry date: Aug2021, intramuscularly, in the left upper arm) for COVID-19 immunisation. On 13May2021, the patient''s asphyxiation symptoms increased and was sent to the hospital. The patient was hospitalized. In the hospital, the patient was treated for respiratory failure but the fatal outcome of advanced lung cancer was unavoidable. The patient died on 15May2021 in the early hours. According to the autopsy report, the cause of death was acute respiratory failure. The patient''s primary diseases that contributed to the death was COPD and advanced lung cancer with multiple metastases. In the patient''s medical history, there is advanced lung cancer, COPD and cardiac decompensation. The patient''s concomitant medicinal products were Berodual (fenoterol, ipratropium bromide), Foster (beclometasone, formoterol), Seebri Breezhaler (glycopyrronium bromide), Retafyllin (theophylline) and Ventolin (salbutamol). No further information is expected. Senders comments: Death after vaccination with Comirnaty is not expected. TTO is 3 weeks until hospitalization. Dechallenge and rechallenge were not applicable. Due to the patient''s primary diseases, the causal relationship between the suspected drug and the events is considered not related. The case is considered serious due to hospitalization and fatal outcome Batch/ lot number: ET6956 No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: acute Respiratory failure; COPD; advanced lung cancer with multiple metastases; advanced lung cancer with multiple metastases; Autopsy-determined Cause(s) of Death: acute Respiratory failure
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166